A Study of JNJ-73763989 in Healthy Chinese Adult Participants
- Conditions
- Healthy
- Interventions
- Drug: JNJ-73763989
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT04586439
- Locations
- π¨π³
Peking University Third Hospital, Beijing, China
A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection
- Conditions
- Hepatitis B
- Interventions
- Drug: JNJ-73763989Drug: JNJ-56136379Drug: Entecavir (ETV)Drug: Tenofovir disoproxilDrug: Tenofovir alafenamide (TAF)Drug: PegIFN-alpha-2a (Optional)
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT04585789
- Locations
- π§πͺ
UZ Antwerpen, Edegem, Belgium
π«π·Hopital Beaujon, Clichy, France
π¨π¦Toronto General Hospital, Toronto, Ontario, Canada
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2020-10-14
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 228
- Registration Number
- NCT04586426
- Locations
- π¨π¦
Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
πΊπΈUniversity of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, Alabama, United States
πΊπΈUniversity of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)
- Conditions
- Respiratory Tract Infections
- Interventions
- First Posted Date
- 2020-10-12
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 28
- Registration Number
- NCT04583280
- Locations
- π§πͺ
UZ Leuven, Leuven, Belgium
π§π¬Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria
ππΊPetz Aladar Megyei Oktato Korhaz, GyΕr, Hungary
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
- Conditions
- Prostatic Neoplasms
- Interventions
- First Posted Date
- 2020-10-08
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 136
- Registration Number
- NCT04577833
- Locations
- π³π±
Erasmus MC, Rotterdam, Netherlands
π΅π±Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warszawa, Poland
π«π·HIA Begin, Saint Mande, France
A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
- First Posted Date
- 2020-10-01
- Last Posted Date
- 2021-10-18
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 34647
- Registration Number
- NCT04571697
- Locations
- πΊπΈ
Janssen R&D, Titusville, New Jersey, United States
A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants
- Conditions
- Healthy
- Interventions
- Drug: JNJ-70033093
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT04569695
- Locations
- π¨π³
West China Hospital, Si Chuan University, Chengdu, China
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 194
- Registration Number
- NCT04557098
- Locations
- πΊπΈ
Winship Cancer Institute Emory University, Atlanta, Georgia, United States
πΊπΈUniversity of California San Francisco, San Francisco, California, United States
π¨π¦University Health Network UHN Princess Margaret Cancer Centre, Toronto, Ontario, Canada
A Study of JNJ-64251330 in Healthy Participants
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 36
- Registration Number
- NCT04552197
- Locations
- π§πͺ
Clinical Pharmacology Unit, Merksem, Belgium
A Study of Seltorexant in Healthy Participants
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 69
- Registration Number
- NCT04553042
- Locations
- πΊπΈ
PRA Health Sciences, Salt Lake City, Utah, United States